Unlimited coverage for anti-rejection drugs moving toward passage.
Republicans defeated an effort by committee Democrats to add their $40 billion proposal prescription drugs to Medicare. Republicans insisted the plan is too big, and that the drug issue should be fought out in another venue.
The Senate Finance Committee was scheduled to discuss its version after this issue of Transplant News went to press.
|Printer friendly Cite/link Email Feedback|
|Article Type:||Brief Article|
|Date:||Oct 6, 2000|
|Previous Article:||HHS splits OPTN, SRTR contracts; bold move may end impasse with UNOS, transplant community over reg.|
|Next Article:||UNOS upgrades data resources available to transplant recipients.|